Autoyos
Asia Pacific Top 20 Medtech Innovator
Asia Pacific Top 20 Medtech Innovator
Global Top 10 in Social Impact domain
Global Top 10 in Social Impact domain
BIRAC BIG Grant winner 2019
BIRAC BIG Grant winner 2019
Best Startup 2019 by Govt. of India
Best Startup 2019 by Govt. of India
People's Choice Award and Best Video Competition
People's Choice Award and Best Video Competition
Previous
Next

Who We Are

At Autoyos, we believe that harnessing technology to revolutionize healthcare is the way forward.  We aim to be at the forefront of the technological transformation of the eye-care industry, bridging the existing gap between care seekers and care providers. In order to address the acute lack of ophthalmic specialists and restricted usage of products/services, we have come up with intelligent Autonomous Medical Systems which can provide comprehensive eye care in non-clinical and resource-poor settings without depending on skilled manpower.

Our Approach

  • Artificial Intelligence
  • Machine Learning
  • Autonomous Medical Systems
  • Tele-ophthalmology​

Why a Radical Solution for
Eye-care is Crucial​

145.6 million people (11.2%) in India suffer from Preventive Blindness and 2 million new cases are registered each year.

There is only 1 ophthalmologist for every 100,000 people in India. This implies that, on average, there is 1 ophthalmologist for every 230 villages.

Of India's permanently blind population of 15 million people, 80% were treatable at an early stage.

Rampant Problems That We Face Today

India is set to emerge as the diabetic capital of the world by 2020. According to the World Health Organization (WHO), 31.7 million people were affected by diabetes mellitus (DM) in India in the year 2000. This figure is estimated to rise to 79.4 million by 2030, the largest number in any nation in the world. Almost two-third of all Type 2 and almost all Type 1 diabetics are expected to develop diabetic retinopathy (DR) over a period of time.

Cataract and Refractive error has been documented to be the first and second most significant cause of bilateral blindness in India respectively. Put together accounts for more than 81% of all blindness affecting 9-12 million bilaterally blind persons.
Glaucoma is the third leading cause of blindness in India accounting for up to 5.8% of total blindness. At least 12 million people affected and nearly 1.2 million people blind from the disease. More than 90 percent of cases of glaucoma remain undiagnosed in the community.

Learn more about:​

Diabetic Retinopathy
Refractive Error
Macular Degeneration
Glaucoma
Cataract

The Eye - A Potent Bio-Marker

The eye acts as an indication of numerous illnesses. In the words of Dr Vázquez, President of the WHO commission on Non-Communicable Diseases (NCDs), 

“NCDs are the world’s leading avoidable killers but the world is not doing enough to prevent and control them.”

Our retinal imaging can be used to detect:

Diabetes Mellitus

Cardio Vascular Diseases

Stroke

Alzheimer's Disease

How Autoyos Helps

For Care Seekers

Doorstep Care

Reduced Disease-Burden

Early Detection

Safe, Secure, Authentic

For Care Providers

Enhanced Reach

Reduced Operator Error and Variability ​

Remote Diagnosis and Tele-Ophthalmology​

Higher Throughput and Increased Revenue

We proudly associate our company with:

Navigation

Address